KBKenneth H. Buetow

Kenneth H. Buetow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kenneth H. Buetow has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Michael Edmonson

    Laboratory of Population Genetics, National Institutes of Health, Bethesda, Maryland, United States of America

    3 shared publications
  • Jinghui Zhang

    Laboratory of Population Genetics, National Cancer Institute/National Institutes of Health, 8424 Helgerman Court, Room 101, MSC 8302, Bethesda, MD 20892-8302, USA

    2 shared publications
  • Robert Clifford

    Laboratory of Population Genetics, Division of Cancer Epidemiology and Genetics, and §Office of Genomics, National Cancer Institute, Bethesda, MD 20892-5060; and ‡Sequenom, Inc., San Diego, CA 92121-1331

    2 shared publications
  • Sol Efroni

    The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel

    2 shared publications
  • Andreas Braun

    Laboratory of Population Genetics, Division of Cancer Epidemiology and Genetics, and §Office of Genomics, National Cancer Institute, Bethesda, MD 20892-5060; and ‡Sequenom, Inc., San Diego, CA 92121-1331

    1 shared publication
  • Anna B. Cassidy

    Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA

    1 shared publication

Latest Publications

    • 19 March 2014
      • Vol. 11  (1) , 1-12

    Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma.

    by Daoud M Meerzaman, Chunhua Yan, Qing-Rong Chen, Michael N Edmonson, Carl F Schaefer, Robert J Clifford, Barbara K Dunn, Li Dong, Richard P Finney, Constance M Cultraro, et al.

    We report on next-generation transcriptome sequencing results of three human hepatocellular carcinoma tumor/tumor-adjacent pairs. This analysis robustly examined ∼12,000 genes for both expression differences and molecular alterations. We observed 4,513 and 1,182 genes demonstrating 2-fold or greater increase or decrease in expression relative to their normal, respectively. Network analysis of expression data identified the Aurora B signaling, FOXM1 transcription factor network and Wnt signaling pathways pairs being altered in HCC. We validated as differential gene expression findings in a large data set containing of 434 liver normal/tumor sample pairs. In addition to known driver mutations in TP53 and CTNNB1, our mutation analysis identified non-synonymous mutations in genes implicated in metabolic diseases, i.e. diabetes and obesity: IRS1, HMGCS1, ATP8B1, PRMT6 and CLU, suggesting a common molecular etiology for HCC of alternative pathogenic origin.


  • Open Access

    Detecting Cancer Gene Networks Characterized by Recurrent Genomic Alterations in a Population

    by Sol Efroni, Rotem Ben-Hamo, Michael Edmonson, Sharon Greenblum, Carl F. Schaefer, Kenneth H. Buetow

    High resolution, system-wide characterizations have demonstrated the capacity to identify genomic regions that undergo genomic aberrations. Such research efforts often aim at associating these regions with disease etiology and outcome. Identifying the corresponding biologic processes that are responsible for disease and its outcome remains challenging. Using novel analytic methods that utilize the structure of biologic networks, we are able to identify the specific networks that are highly significantly, nonrandomly altered by regions of copy number amplification observed in a systems-wide analysis. We demonstrate this method in breast cancer, where the state of a subset of the pathways identified through these regions is shown to be highly associated with disease survival and recurrence.


  • Enabling Personalized Medicine Through an Interoperable it Infrastructure: An Overview of the Cancer Biomedical Informatics Grid ®

    by Kenneth H Buetow

    To implement personalized medicine successfully, multidisciplinary teams of collaborating scientists must manage and analyze vast quantities of genomic and clinical outcomes data in a cohesive and integrated way. This process is complex and not supported by the existing IT infrastructure and tools available to most researchers. To address these needs, the National Cancer Institute initiated the cancer Biomedical Informatics Grid initiative in 2004, to develop and deploy the interoperable IT infrastructure and tools needed to help basic and clinical researchers manage and share these data. Now, the cancer Biomedical Informatics Grid is being deployed to cancer centers and other biomedical research organizations across the USA and around the world, facilitating collaborative research that will ultimately lead to improved patient outcomes.


  • Open Access

    Superposition of Transcriptional Behaviors Determines Gene State

    by Sol Efroni, Liran Carmel, Carl G. Schaefer, Kenneth H. Buetow

    We introduce a novel technique to determine the expression state of a gene from quantitative information measuring its expression. Adopting a productive abstraction from current thinking in molecular biology, we consider two expression states for a gene - Up or Down. We determine this state by using a statistical model that assumes the data behaves as a combination of two biological distributions. Given a cohort of hybridizations, our algorithm predicts, for the single reading, the probability of each gene's being in an Up or a Down state in each hybridization. Using a series of publicly available gene expression data sets, we demonstrate that our algorithm outperforms the prevalent algorithm. We also show that our algorithm can be used in conjunction with expression adjustment techniques to produce a more biologically sound gene-state call. The technique we present here enables a routine update, where the continuously evolving expression level adjustments feed into gene-state calculations. The technique can be applied in almost any multi-sample gene expression experiment, and holds equal promise for protein abundance experiments.


  • Open Access

    Gene functional similarity search tool (GFSST)

    by Peisen Zhang, Jinghui Zhang, Huitao Sheng, James J Russo, Brian Osborne, Kenneth Buetow

    Background: With the completion of the genome sequences of human, mouse, and other species and the advent of high throughput functional genomic research technologies such as biomicroarray chips, more and more genes and their products have been discovered and their functions have begun to be understood. Increasing amounts of data about genes, gene products and their functions have been stored in databases. To facilitate selection of candidate genes for gene-disease research, genetic association studies, biomarker and drug target selection, and animal models of human diseases, it is essential to have search engines that can retrieve genes by their functions from proteome databases. In recent years, the development of Gene Ontology (GO) has established structured, controlled vocabularies describing gene functions, which makes it possible to develop novel tools to search genes by functional similarity. Results: By using a statistical model to measure the functional similarity of genes based on the Gene Ontology directed acyclic graph, we developed a novel Gene Functional Similarity Search Tool (GFSST) to identify genes with related functions from annotated proteome databases. This search engine lets users design their search targets by gene functions. Conclusion: An implementation of GFSST which works on the UniProt (Universal Protein Resource) for the human and mouse proteomes is available at GFSST Web Server. GFSST provides functions not only for similar gene retrieval but also for gene search by one or more GO terms. This represents a powerful new approach for selecting similar genes and gene products from proteome databases according to their functions.


  • Cyberinfrastructure: Empowering a "Third Way" in Biomedical Research

    by Kenneth H. Buetow

    Biomedicine has experienced explosive growth, fueled in parts by the substantial increase of government support, continued development of the biotechnology industry, and the increasing adoption of molecular-based medicine. At its core, it is composed of fiercely independent, innovative, entrepreneurial individuals, organizations, and institutions. The field has developed unprecedented capacity to characterize biologic systems at their most fundamental levels with the use of tools and technologies almost unimaginable a generation ago. Biomedicine is at the precipice of unlocking the very essence of biologic life and enabling a new generation of medicine. Development and deployment of cyberinfrastructure may prove to be on the critical path to obtaining these goals.


  • Open Access

    High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

    by Kenneth H. Buetow, Michael Edmonson, Richard MacDonald, Robert Clifford, Ping Yip, Jenny Kelley, Daniel P. Little, Robert Strausberg, Hubert Koester, Charles R. Cantor, et al.

    We describe here a system for the rapid identification, assay development, and characterization of gene-based single nucleotide polymorphisms (SNPs). This system couples informatics tools that mine candidate SNPs from public expressed sequence tag resources and automatically designs assay reagents with detection by a chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry platform. As a proof of concept of this system, a genomewide collection of reagents for 9,115 gene-based SNP genetic markers was rapidly developed and validated. These data provide preliminary insights into patterns of polymorphism in a genomewide collection of gene-based polymorphisms.


  • Open Access

    Expression-based Genetic/Physical Maps of Single-Nucleotide Polymorphisms Identified by the Cancer Genome Anatomy Project

    by Robert Clifford, Michael Edmonson, Ying Hu, Cu Nguyen, Titia Scherpbier, Kenneth H. Buetow

    SNPs (Single-Nucleotide Polymorphisms), the most common DNA variant in humans, represent a valuable resource for the genetic analysis of cancer and other illnesses. These markers may be used in a variety of ways to investigate the genetic underpinnings of disease. In gene-based studies, the correlations between allelic variants of genes of interest and particular disease states are assessed. An extensive collection of SNP markers may enable entire molecular pathways regulating cell metabolism, growth, or differentiation to be analyzed by this approach. In addition, high-resolution genetic maps based on SNPs will greatly facilitate linkage analysis and positional cloning. The National Cancer Institute's CGAP-GAI (Cancer Genome Anatomy Project Genetic Annotation Initiative) group has identified 10,243 SNPs by examining publicly available EST (Expressed Sequence Tag) chromatograms. More than 6800 of these polymorphisms have been placed on expression-based integrated genetic/physical maps. In addition to a set of comprehensive SNP maps, we have produced maps containing single nucleotide polymorphisms in genes expressed in breast, colon, kidney, liver, lung, or prostate tissue. The integrated maps, a SNP search engine, and a Java-based tool for viewing candidate SNPs in the context of EST assemblies can be accessed via the CGAP-GAI web site (http://cgap.nci.nih.gov/GAI/). Our SNP detection tools are available to the public for noncommercial use. [The sequence data described in this paper have been submitted to the db SNP data library under accession nos. SS8196–SS18418.]